Optimization of Immobilized Aldose Reductase Isolated from Bovine Liver Sığır Karaciğerinden İzole Edilen İmmobilize Aldoz Redüktazın Optimizasyonu

Total Page:16

File Type:pdf, Size:1020Kb

Optimization of Immobilized Aldose Reductase Isolated from Bovine Liver Sığır Karaciğerinden İzole Edilen İmmobilize Aldoz Redüktazın Optimizasyonu Turk J Pharm Sci 2019;16(2):206-210 DOI: 10.4274/tjps.galenos.2018.81894 ORIGINAL ARTICLE Optimization of Immobilized Aldose Reductase Isolated from Bovine Liver Sığır Karaciğerinden İzole Edilen İmmobilize Aldoz Redüktazın Optimizasyonu Marya Vakıl NASLIYAN, Sidar BEREKETOĞLU, Özlem YILDIRIM* Ankara University, Faculty of Science, Department of Biology, Ankara, Turkey ABSTRACT Objectives: Isolation of enzymes and experiments on them require great effort and cost and are time-consuming. Therefore, it is important to extend the usability of the enzymes by immobilizing them. In this study our purpose was to immobilize the enzyme aldose reductase (AR) and to optimize the experimental conditions of the immobilized AR and compare them to those of free AR. Materials and Methods: AR was isolated from bovine liver and the enzyme immobilized in photographic gelatin by cross-linking with glutaraldehyde. Then the optimum conditions for free and immobilized AR in terms of pH, temperature, and storage were characterized by determining the enzyme activity. Results: Following immobilization, the optimum pH and temperature levels for free AR, which were pH 7.0 and 60°C, slightly altered to pH 7.5 and 50°C. The enzyme activity of the immobilized AR was maintained at about 65% after reusing 15 times. Moreover, immobilized AR maintained 95% of its original activity after 20 days of storage at 4°C, while the retained activity of the free AR was 85% of the original. Conclusion: Our experiments indicated that the conditions that affect enzyme activity might alter following immobilization. Once the optimum experimental conditions are fixed, the immobilized AR can be stored and reused with efficiency higher than that of free AR. Moreover, this study provides an insight into the advantages of using immobilized AR in enzyme assays rather than free AR. Key words: Aldose reductase, isolation, immobilization ÖZ Amaç: Enzim izolasyonu ve enzimler üzerinde yapılan deneyler, büyük çaba, maliyet ve zaman gerektirir. Bu yüzden, enzimlerin kullanılabilirliğinin immobilizasyon ile uzatılması önemlidir. Bu çalışmadaki amacımız, aldoz redüktaz (AR) enzimini immobilize etmek ve serbest AR’ninkiler ile karşılaştırarak immobilize AR’nin deney şartlarını optimize etmektir. Gereç ve Yöntemler: AR, sığır karaciğer ve böbreğinden izole edildi ve gluteraldehid ile fotografik jelatine çapraz bağlanarak immobilize edildi. Daha sonra, enzim aktivitesi belirlenerek serbest ve immobilize AR’nin optimum pH, sıcaklık ve depolama koşulları tespit edildi. Bulgular: Serbest AR için pH 7.0 ve 60°C olan optimum pH ve sıcaklık seviyeleri, immobilizasyondan sonra pH 7.5 ve 50°C olarak belirlendi. İmmobilize AR’nin enzim aktivitesinin, 15 kez kullanımdan sonra %65 oranında korunduğu tespit edildi. Bununla birlikte, +4°C’de 20 gün boyunca saklanan serbest AR’nin aktivitesi %85 oranında korunurken immobilize AR’nin aktivitesinin %95 oranında korunduğu bulunmuştur. Sonuç: Deneylerimiz, immobilizasyonu takiben enzim aktivitesini etkileyen koşulların değişebileceğini göstermektedir. Ayrıca, immobilize AR, serbest AR’ye göre daha yüksek aktiviteyle korunup tekrar tekrar kullanılabilmektedir. Anahtar kelimeler: Aldoz redüktaz, izolasyon, immobilizasyon *Correspondence: E-mail: [email protected], Phone: +90 532 471 60 46 ORCID-ID: orcid.org/0000-0002-7529-9786 Received: 28.02.2018, Accepted: 29.03.2018 ©Turk J Pharm Sci, Published by Galenos Publishing House. 206 NASLIYAN et al. Immobilized Aldose Reductase 207 INTRODUCTION followed by rotation at 10,000 rpm at +4°C for 25 min. To gain Aldose reductase (AR) (EC 1.1.1.21) is expressed by the AKR1B1 50% and 75% saturations, the same method was carried out by gene in humans. It is located on the 7q35 chromosome, consists adding 5.8 g and 15.9 g of ammonium sulfate to the 100 mL of of 315 amino acids, and its molecular weight is 36 kD. AR is a supernatant solution, respectively. The pellets were dissolved cytosolic monomeric protein.1 It specifically catalyzes the polyol with 50 mM sodium chloride and stored in a freezer at -80°C. pathway, which includes the conversion of glucose-bound Determining the protein amount nicotinamide adenine dinucleotide phosphate (NADPH) cofactor Following isolation, the amount of protein was detected by to sorbitol.2,3 Moreover, it reduces the activity of aldehydes Bradford assay.9 The bovine serum albumin (BSA) standards such as glutathione complexes.4 Indeed, AR is crucial in the were used at the concentrations of 0.4, 0.6, 0.8, 1.0, 1.2, and detoxification of lipid aldehydes produced by oxidative stress.5 1.4 mg/mL. BIO-RAD reagent was added to the BSA standards Under optimum conditions, enzymes are able to display and the sample. Then each solution was measured using a their activities outside of their natural environment. Using spectrophotometer at 595 nm wavelength. Finally, protein this feature, they can be employed on a large scale in health amount was calculated using the standard graph generated science, such as in the diagnosis and treatment of diseases with optical densities of the standards. and drug design. However, their structure tends to alter during the experimental process. Therefore, studies aim to improve Assay of AR enzyme activity the conformational stability of enzymes.6 Immobilization is a AR activity was detected against DL-glyceraldehyde, by method reducing disruption of the enzyme structure. Enzyme monitoring the NADPH oxidation to NADP+ at 340 nm.10 The immobilization avoids the majority of the instability and loss of reaction mixture consisted of AR enzyme (4.54 mg/mL), -5 enzyme activity. This provides a longer time and flexibility to NADPH (9×10 M), Li2SO4 (320 mM-400 mM), DL-glyceraldehyde work on enzymes. Immobilization is not only useful to maintain (6×10-4 M), and KP buffer (50 mM, pH 6.2). NADP+ oxidation the stability of biomolecules but also it reduces the cost of was followed in 0.25 mL of reaction mixture using a multimode enzyme studies. microplate reader at 340 nm for 4 min. Initial and final rates In the present study for the first time AR was isolated from of enzymatic reactions were measured and recorded as nmol/ bovine liver, immobilized, and characterized with respect to min/mg protein. several kinetic properties. In addition, AR derived from bovine Immobilization of AR enzyme kidney was used as a side control and simultaneously applied The immobilization gel consisted of 0.025 g of photographic to identical experiments. The AR enzymes from both sources gelatin and 0.125 M glutaraldehyde in 0.067 M phosphate were immobilized in gelatin by glutaraldehyde and washed to tampon solution (pH 7.4). The photographic gelatin was remove the free enzyme. We compared the behavior of the prepared at 50°C and then cooled to 30-35°C. Different units of free and the immobilized AR under different conditions of pH, AR enzyme were added to the gelatin and then vortexed. Cross- temperature, reusing, and storage. The difference in optimum linking glutaraldehyde was included at the concentration of conditions of the free and the immobilized enzyme may be 5×10-5 M. Then 100 μL of the mixture was placed onto cellulose due to alterations in the structure caused by several factors triacetate. Enzyme and gelatin complexes were dried for 24 h such as carrier material, immobilization method, and activation at room temperature. method.7 Indeed it was previously indicated that immobilization significantly changes the conformation of enzymes and thus The film strips carrying the immobilized AR were assayed their activity.8 for enzyme activity. The reaction mixture consisted of 2.7 mL of potassium phosphate, 0.1 mL of NADPH, and 0.1 mL MATERIALS AND METHODS DL-glyceraldehyde. Absorbance of this reaction mixture was measured at 340 nm before and after 20 min incubation with Chemical materials the film strips to detect enzyme activity. In this research, ethylenediaminetetraacetic acid (EDTA), NADPH, and lithium sulfate (Li2SO4) were purchased from RESULTS AND DISCUSSION Gerbu, Germany. Ammonium sulfate was supplied by Merck. AR isolated from bovine liver was immobilized by cross- Phenylmethylsulfonyl fluoride (PMSF), DL-glyceraldehyde, and linking with glutaraldehyde in photographic gelatin. To detect all other materials used were analytically graded and obtained the amount of AR protein we used the Bradford assay and from Sigma Aldrich, Germany. spectrophotometric measurements. The results indicated that Isolation of AR enzyme from bovine liver the protein amount was 18.39±0.09 mg/mL. In the standard -4 The bovine liver was provided by a slaughterhouse in Kazan, group, the activity values for only AR were 4.172×10 U/L in Ankara, Turkey. Small pieces of liver samples were washed liver. These values are accepted as 100% enzyme activity. with 1.0 mM EDTA. Then they were measured and homogenized Following immobilization, the free enzyme was removed by with threefold 1.0 mM EDTA and 50 μM PMSF and spun at +4°C washing the film strips three times with phosphate buffer and 10,000 rpm for 30 min. To acquire 40% saturation, 22.6 g (0.067 M, pH 6.2) at 25°C for 5 min and spectrophotometry was of ammonium sulfate was added to each 100 mL of supernatant used to detect the amount of free enzyme. Using the washed 208 NASLIYAN et al. Immobilized Aldose Reductase film strips, the effect of enzyme concentration on immobilized We observed that the optimum pH for AR shifted to 7.5 from 7.0 enzyme activity was tested to detect the immobilized enzyme upon immobilization. This alteration should be because of the leakage. Our results showed that AR leakage from the film strips H+ and the OH- ions that are released into the microenvironment increased with enzyme concentration while the enzyme activity during the reaction. Indeed, this result about the optimum was reduced after each wash. On the other hand, three washes pH alteration was expected because of the context of the were sufficient to remove the leakage completely (Table 1).
Recommended publications
  • Glucose Oxidase
    Catalog Number: 100289, 100330, 195196 Glucose Oxidase Molecular Weight: ~160,0001 CAS #: 9001-34-0 Physical Description: Yellow lyophilized powder Source: Aspergillus niger Isoelectric Point: 4.2 Michaelis Constants: phosphate buffer, pH 5.6; 25°C, air: Glucose: 3.3 x 10-2 mol/l(2) Glucose: 1.1 x 10-1 mol/l(3) 2-Deoxyglucose: 2.5 x 10-2 mol/l O2: 2.0 x 10-4 mol/l Structure: The enzyme contains 2 moles FAD/mole GOD. Inhibitors: Ag+, Hg2+, Cu2+ (4), 4-chloromercuribenzoate, D-arabinose (50%). FAD binding is inhibited by several nucleotides.5 pH Optimum: 6.5 pH Stability: 8.0 pH Range: 4-7 Thermal Stability: Below 40°C Description: Glucose oxidase is an FAD-containing glycoprotein. The enzyme is specific for b-D-glucose. O2 can be replaced by hydrogen acceptors such as 2.6-dichlorophenol indophenol. Relative Rates: D-glucose, 100; D-mannose, 20; 2-Deoxy-D-glucose, 20; negligible on other hexoses. Solubility: Dissolves readily at 5 mg/ml in 0.1 M potassium phosphate pH 7.0, giving a clear, yellow solution, also soluble in water Assay Procedure 1: Unit Definition: One unit of glucose oxidase is the activity which causes the liberation of 1 micromole of H2O2 per minute at 25°C and pH 7.0 under the specified conditions. Reaction: Reagents: 1. 0.1 M Phosphate Buffer, pH 6.8: dissolve 6.8 g of potassium phosphate, monobasic, anhydrous and 7.1 g of sodium phosphate, dibasic, anhydrous in about 800 ml of deionized water. Adjust the pH to 6.8 ± 0.05 @ 25°C with 1 N HCl or 1N NaOH if necessary.
    [Show full text]
  • Fructose As an Endogenous Toxin
    HEPATOCYTE MOLECULAR CYTOTOXIC MECHANISM STUDY OF FRUCTOSE AND ITS METABOLITES INVOLVED IN NONALCOHOLIC STEATOHEPATITIS AND HYPEROXALURIA By Yan (Cynthia) Feng A thesis submitted in the conformity with the requirements for the degree of Master of Science Graduate Department of Pharmaceutical Sciences University of Toronto © Copyright by Yan (Cynthia) Feng 2010 ABSTRACT HEPATOCYTE MOLECULAR CYTOTOXIC MECHANISM STUDY OF FRUCTOSE AND ITS METABOLITES INVOLVED IN NONALCOHOLIC STEATOHEPATITIS AND HYPEROXALURIA Yan (Cynthia) Feng Master of Science, 2010 Department of Pharmaceutical Sciences University of Toronto High chronic fructose consumption is linked to a nonalcoholic steatohepatitis (NASH) type of hepatotoxicity. Oxalate is the major endpoint of fructose metabolism, which accumulates in the kidney causing renal stone disease. Both diseases are life-threatening if not treated. Our objective was to study the molecular cytotoxicity mechanisms of fructose and some of its metabolites in the liver. Fructose metabolites were incubated with primary rat hepatocytes, but cytotoxicity only occurred if the hepatocytes were exposed to non-toxic amounts of hydrogen peroxide such as those released by activated immune cells. Glyoxal was most likely the endogenous toxin responsible for fructose induced toxicity formed via autoxidation of the fructose metabolite glycolaldehyde catalyzed by superoxide radicals, or oxidation by Fenton’s hydroxyl radicals. As for hyperoxaluria, glyoxylate was more cytotoxic than oxalate presumably because of the formation of condensation product oxalomalate causing mitochondrial toxicity and oxidative stress. Oxalate toxicity likely involved pro-oxidant iron complex formation. ii ACKNOWLEDGEMENTS I would like to dedicate this thesis to my family. To my parents, thank you for the sacrifices you have made for me, thank you for always being there, loving me and supporting me throughout my life.
    [Show full text]
  • A High-Throughput Screening System Based on Droplet Microfluidics For
    molecules Article A High-Throughput Screening System Based on Droplet Microfluidics for Glucose Oxidase Gene Libraries Radivoje Prodanovi´c 1,2,* , W. Lloyd Ung 2, Karla Ili´c Đurđi´c 1 , Rainer Fischer 3, David A. Weitz 2 and Raluca Ostafe 4 1 Faculty of Chemistry, University of Belgrade, Studentski trg 12, 11000 Belgrade, Serbia; [email protected] 2 Department of Physics, School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA; [email protected] (W.L.U.); [email protected] (D.A.W.) 3 Departments of Biological Sciences and Chemistry, Purdue University, 207 S. Martin Jischke Dr., West Lafayette, IN 47907, USA; fi[email protected] 4 Purdue Institute of Inflammation, Immunology and Infectious Disease, Molecular Evolution, Protein Engineering and Production, Purdue University, 207 S. Martin Jischke Dr., West Lafayette, IN 47907, USA; [email protected] * Correspondence: [email protected]; Tel.: +38-111-333-6660 Academic Editors: Goran T. Vladisavljevi´cand Guido Bolognesi Received: 20 April 2020; Accepted: 15 May 2020; Published: 22 May 2020 Abstract: Glucose oxidase (GOx) is an important industrial enzyme that can be optimized for specific applications by mutagenesis and activity-based screening. To increase the efficiency of this approach, we have developed a new ultrahigh-throughput screening platform based on a microfluidic lab-on-chip device that allows the sorting of GOx mutants from a saturation mutagenesis library expressed on the surface of yeast cells. GOx activity was measured by monitoring the fluorescence of water microdroplets dispersed in perfluorinated oil. The signal was generated via a series of coupled enzyme reactions leading to the formation of fluorescein.
    [Show full text]
  • The Genome of an Industrial Workhorse
    NEWS AND VIEWS The genome of an industrial workhorse Dan Cullen Sequencing of the filamentous fungus Aspergillus niger offers new opportunities for the production of specialty chemicals and enzymes. Few microbes compare with the filamentous fungus Aspergillus niger in its ability to pro­ Environment CAT (2) H O H O + O duce prodigious amounts of useful chemicals 2 2 2 2 and enzymes. This fungus is the principal GOX (3) GLN (1) source of citric acid for food, beverages and D-glucono­ Glucose Gluconate Oxalate pharmaceuticals1 and of several important 1,5-lactone Citrate http://www.nature.com/naturebiotechnology http://www.nature.com/naturebiotechnology commercial enzymes, including glucoamy­ lase, which is widely used for the conversion of starch to food syrups and to fermentative Oxalate + acetate PEP feedstocks for ethanol production. Although OAH most of these fermentation processes are well cMDH (3) established, the underlying genetics are still cPYC (1) cACO (2) cIDH (1) poorly understood. In this issue, Pel et al.2 Pyruvate OAA MAL Citrate Isocitrate 2-ketoglutarate report the genome sequence of A. niger strain Cytosol CBS 513.88. The availability of this sequence OAT (1) CMC (2) mPYC (1) should provide invaluable aid toward improv­ Pyruvate OAA MAL Citrate Isocitrate 2-ketoglutarate ing the production of chemicals and enzymes PDH Nature Publishing Group Group Nature Publishing 7 in this organism. mMDH (1) mACO (2) mIDH (3) Pel et al. sequenced tiled bacterial artificial CS (3) 200 Acetyl-CoA TCA cycle © chromosomes representing the entire A. niger genome to produce a high-quality assembly of Mitochondrion 19 supercontigs with a combined length of 33.9 Mb.
    [Show full text]
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,458,686 Clark, Jr
    United States Patent (19) 11 Patent Number: 4,458,686 Clark, Jr. 45) Date of Patent: Jul. 10, 1984 (54), CUTANEOUS METHODS OF MEASURING 4,269,516 5/1981 Lubbers et al. ..................... 356/427 BODY SUBSTANCES 4,306,877 12/1981 Lubbers .............................. 128/633 Primary Examiner-Benjamin R. Padgett 75) Inventor: Leland C. Clark, Jr., Cincinnati, Ohio Assistant Examiner-T. J. Wallen 73. Assignee: Children's Hospital Medical Center, Attorney, Agent, or Firm-Wood, Herron & Evans Cincinnati, Ohio 57 ABSTRACT (21) Appl. No.: 491,402 Cutaneous methods for measurement of substrates in 22 Filed: May 4, 1983 mammalian subjects are disclosed. A condition of the skin is used to measure a number of important sub - Related U.S. Application Data stances which diffuse through the skin or are present (62) Division of Ser. No. 63,159, Aug. 2, 1979, Pat. No. underneath the skin in the blood or tissue. According to 4,401,122. the technique, an enzyme whose activity is specific for a particular substance or substrate is placed on, in or 51). Int. Cl. ................................................ A61B5/00 under the skin for reaction. The condition of the skin is 52). U.S. Cl. .................................... 128/635; 128/636; then detected by suitable means as a measure of the 436/11 amount of the substrate in the body. For instance, the (58), Field of Search ............... 128/632, 635, 636, 637, enzymatic reaction or by-product of the reaction is 128/633; 356/41, 417, 427; 422/68; 23/230 B; detected directly through the skin as a measure of the 436/11 amount of substrate.
    [Show full text]
  • Metabolism of Carbohydrates by Pasteurella Pseudotuberculosis' R
    JOURNAL OF BACrERiOLOGY, May 1968, p. 1698-1705 Vol. 95, No. 5 Copyright 0) 1968 American Society for Microbiology Printed In U.S.A. Metabolism of Carbohydrates by Pasteurella pseudotuberculosis' R. R. BRUBAKER2 Department ofMicrobiology, The University ofChicago, Chicago, Illinois 60637 Received for publication 26 February 1968 Cell-free extracts of Pasteurella pseudotuberculosis and P. pestis catalyzed a rapid and reversible exchange of electrons between pyridine nucleotides. Although the extent of this exchange approximated that promoted by the soluble nicotinamide adenine dinucleotide (phosphate) transhydrogenase of Pseudomonas fluorescens, the reaction in the pasteurellae was associated with a particulate fraction and was not influenced by adenosine-2'-monophosphate. The ability of P. pseudotubercu- losis to utilize this system for the maintenance of a large pool of nicotinamide ade- nine dinucleotide phosphate could not be correlated with significant participation of the Entner-Doudoroff path or catabolic use of the hexose-monophosphate path during metabolism of glucose. As judged by the distribution of radioactivity in metabolic pyruvate, glucose and gluconate were fermented via the Embden-Meyerhof and Entner-Doudoroff paths, respectively. With the exception of hexosediphospha- tase, all enzymes of the three paths were detected, although little or no glucono- kinase or phosphogluconate dehydrase was present unless the organisms were cultivated with gluconate. The significance of these findings is discussed with respect to the regulation of carbohydrate metabolism in the pasteurellae, related enteric bacteria, and P. fluorescens. Glucose is catabolized by Pasteurella pestis, fate of glucose-6-phosphate in P. pestis. The the causative agent of bubonic plague, via the possibility exists, however, that excess NADP Embden-Meyerhof path (29), whereas gluconate in P.
    [Show full text]
  • Glucose Oxidase
    www.megazyme.com GLUCOSE OXIDASE ASSAY PROCEDURE K-GLOX 01/20 (200 Manual Assays per Kit) or (1960 Auto-Analyser Assays per Kit) or (2000 Microplate Assays per Kit) © Megazyme 2020 INTRODUCTION: Glucose oxidase (GOX) catalyses the oxidation of β-D-glucose to D-glucono-δ-lactone and hydrogen peroxide. It is highly specific for β-D-glucose and does not act on α-D-glucose. A major use of glucose oxidase has been in the determination of free glucose in body fluids, food and agricultural products. However, it has been gaining increasing attention in the baking industry; its oxidising effects result in a stronger dough. In some applications it can be used to replace oxidants, such as bromate and L-ascorbic acid. Other uses of glucose oxidase include the removal of oxygen from food packaging and removal of D-glucose from egg white to prevent browning. PRINCIPLE: Glucose oxidase catalyses the oxidation of β-D-glucose to D-glucono- δ-lactone with the concurrent release of hydrogen peroxide (1). In the presence of peroxidase (POD), this hydrogen peroxide (H2O2) enters into a second reaction involving p-hydroxybenzoic acid and 4-aminoantipyrine with the quantitative formation of a quinoneimine dye complex which is measured at 510 nm (2). The reactions involved are: (GOX) (1) β-D-Glucose + O2 + H2O D-glucono-δ-lactone + H2O2 (2) 2H2O2 + p-hydroxybenzoic acid + 4-aminoantipyrine (POD) quinoneimine dye + 4H2O SAFETY: The general safety measures that apply to all chemical substances should be adhered to. For more information regarding the safe usage and handling of this product please refer to the associated SDS that is available from the Megazyme website.
    [Show full text]
  • Investigation of Tumor Hypoxia Using A
    Askoxylakis et al. Radiation Oncology 2011, 6:35 http://www.ro-journal.com/content/6/1/35 RESEARCH Open Access Investigation of tumor hypoxia using a two- enzyme system for in vitro generation of oxygen deficiency Vasileios Askoxylakis1,5*, Gunda Millonig2, Ute Wirkner1,3, Christian Schwager1,3, Shoaib Rana4, Annette Altmann5, Uwe Haberkorn4,5, Jürgen Debus1, Sebastian Mueller2 and Peter E Huber1,3 Abstract Background: Oxygen deficiency in tumor tissue is associated with a malign phenotype, characterized by high invasiveness, increased metastatic potential and poor prognosis. Hypoxia chambers are the established standard model for in vitro studies on tumor hypoxia. An enzymatic hypoxia system (GOX/CAT) based on the use of glucose oxidase (GOX) and catalase (CAT) that allows induction of stable hypoxia for in vitro approaches more rapidly and with less operating expense has been introduced recently. Aim of this work is to compare the enzymatic system with the established technique of hypoxia chamber in respect of gene expression, glucose metabolism and radioresistance, prior to its application for in vitro investigation of oxygen deficiency. Methods: Human head and neck squamous cell carcinoma HNO97 cells were incubated under normoxic and hypoxic conditions using both hypoxia chamber and the enzymatic model. Gene expression was investigated using Agilent microarray chips and real time PCR analysis. 14C-fluoro-deoxy-glucose uptake experiments were performed in order to evaluate cellular metabolism. Cell proliferation after photon irradiation was investigated for evaluation of radioresistance under normoxia and hypoxia using both a hypoxia chamber and the enzymatic system. Results: The microarray analysis revealed a similar trend in the expression of known HIF-1 target genes between the two hypoxia systems for HNO97 cells.
    [Show full text]
  • GRAS Notice No. GRN 000707, Glucose Oxidase from Penicillium
    . Candice Cryne AB Enzymes GmbH Feldbergstr. 78 D-64293 Darmstadt, GERMANY Re: GRAS Notice No. GRN 000707 Dear Ms. Cryne: The Food and Drug Administration (FDA, we) completed our evaluation of GRN 000707. We received AB Enzymes GmbH (AB Enzymes)’s GRAS notice on May 16, 2017 and filed it on June 22, 2017. We received amendments containing additional safety information on June 22, 2017, and October 27, 2017. The subject of the notice is glucose oxidase enzyme preparation produced by Trichoderma reesei expressing a modified synthetic gene encoding glucose oxidase from Penicillium amagasakiense (glucose oxidase enzyme preparation) for use as an enzyme in the production of baked goods and cereal-based products at a maximum level of 10 mg Total Organic Solids (TOS)/kg flour. The notice informs us of AB Enzymes’ view that these uses of glucose oxidase enzyme preparation are GRAS through scientific procedures. Commercial enzyme preparations that are used in food processing typically contain an enzyme component that catalyzes the chemical reaction as well as substances used as stabilizers, preservatives, or diluents. Enzyme preparations may also contain components derived from the production organism and from the manufacturing process, e.g., constituents of the fermentation media or the residues of processing aids. AB Enzymes’ notice provides information about the components in the glucose oxidase enzyme preparation. According to the classification system of enzymes established by the International Union of Biochemistry and Molecular Biology, glucose oxidase is identified by the Enzyme Commission Number 1.1.3.4. The accepted name and systematic name is glucose oxidase. This enzyme is also known as ǃ-D-glucose oxidase, ǃ-D-glucose: quinone oxidoreductase, D-glucose oxidase, D-glucose-1-oxidase, glucose oxyhydrase, deoxin-1, glucose aerodehydrogenase, aero-glucose dehydrogenase, glucose oxyhydrase, notatin, corylophyline, and penatin.
    [Show full text]
  • Abuse-Deterrent Pharmaceutical Compositions
    (19) TZZ¥ _Z¥Z_T (11) EP 3 210 630 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 30.08.2017 Bulletin 2017/35 A61K 47/36 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) (2006.01) (2006.01) (21) Application number: 16157803.4 A61K 31/455 A61K 31/485 (22) Date of filing: 29.02.2016 (84) Designated Contracting States: (71) Applicant: G.L. Pharma GmbH AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 8502 Lannach (AT) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (72) Inventor: The designation of the inventor has not Designated Extension States: yet been filed BA ME Designated Validation States: (74) Representative: Sonn & Partner Patentanwälte MA MD Riemergasse 14 1010 Wien (AT) (54) ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS (57) Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone. EP 3 210 630 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 210 630 A1 Description [0001] The present application relates to abuse-deterrent pharmaceutical compositions comprising oxycodone. [0002] Prescription opioid products are an important component of modern pain management. However, abuse and 5 misuse of these products have created a serious and growing public health problem. One potentially important step towards the goal of creating safer opioid analgesics has been the development of opioids that are formulated to deter abuse.
    [Show full text]
  • Directed Evolution of Cellobiose Dehydrogenase on the Surface of Yeast Cells Using Resazurin-Based Fluorescent Assay
    applied sciences Article Directed Evolution of Cellobiose Dehydrogenase on the Surface of Yeast Cells Using Resazurin-Based Fluorescent Assay Marija Blaži´c 1, Ana Marija Balaž 1, Olivera Prodanovi´c 2, Nikolina Popovi´c 3, Raluca Ostafe 4, Rainer Fischer 5,6 and Radivoje Prodanovi´c 3,* 1 Institute of Chemistry, Technology and Metallurgy, University of Belgrade, Njegoševa 2, 11000 Belgrade, Serbia; [email protected] (M.B.); [email protected] (A.M.B.) 2 Institute for Multidisciplinary Studies, University of Belgrade, Kneza Višeslava 1, 11030 Belgrade, Serbia; [email protected] 3 Faculty of Chemistry, University of Belgrade, Studentski trg 12, 11000 Belgrade, Serbia; [email protected] 4 Molecular Evolution Protein Engineering and Production facility (MEPEP), Purdue University, 207 S. Martin Jischke Dr., West Lafayette, IN 47907, USA; [email protected] 5 Indiana Bioscience Research Institute, Single Cell Analytics Center, 1345 W. 16th St. Suite 300, Indianapolis, IN 46202, USA; rfi[email protected] 6 Institute of Molecular Biotechnology, RWTH Aachen University Worringerweg 1, 52074 Aachen, Germany * Correspondence: [email protected]; Tel.: +381-11-333-6660 Received: 8 March 2019; Accepted: 1 April 2019; Published: 3 April 2019 Featured Application: Developed fluorescent assay and expression system can be used for obtaining improved cellobiose dehydrogenase whole cell biocatalysts for lactobionic acid production and building of biosensors and biofuel cells. Abstract: Cellobiose dehydrogenase (CDH) from Phanerochaete chrysosporium can be used in lactobionic acid production, biosensor for lactose, biofuel cells, lignocellulose degradation, and wound-healing applications. To make it a better biocatalyst, CDH with higher activity in an immobilized form is desirable.
    [Show full text]